Literature DB >> 3148698

Intracellular distribution of photosensitizing porphyrins measured by video-enhanced fluorescence microscopy.

H Schneckenburger1, A Rück, B Bartos, R Steiner.   

Abstract

The intracellular distribution of photosensitizing porphyrins with different amounts of aggregates was measured in a fluorescence microscope using video-intensified detection and image processing. Porphyrin fluorescence was localized in the plasma membrane, cytoplasm, nuclear membrane and nucleoli. The fluorescence intensity in the plasma membrane decreased with increasing aggregation of the photosensitizers. In addition, a redistribution of the porphyrin molecules from the plasma membrane to the nuclear membrane and adjacent intracellular sites was observed with increasing incubation time. Photobleaching of porphyrin fluorescence was most pronounced in the plasma membrane and least efficient within the nucleoli.

Mesh:

Substances:

Year:  1988        PMID: 3148698     DOI: 10.1016/1011-1344(88)85054-1

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  Development of a laser-based fluorescence microscope with subnanosecond time resolution.

Authors:  A D Scully; A J Macrobert; S Botchway; P O'Neill; A W Parker; R B Ostler; D Phillips
Journal:  J Fluoresc       Date:  1996-06       Impact factor: 2.217

2.  Uptake and phototoxic effects of aluminum-chlorophthalocyanine (AlSPc) in human bladder carcinoma cells.

Authors:  K Miller; E Reich; T Grau; R Hautmann
Journal:  Urol Res       Date:  1994

3.  In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.

Authors:  Sami El Khatib
Journal:  Curr Urol       Date:  2021-03-29

4.  Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.

Authors:  G Karagianis; J S Hill; S S Stylli; A H Kaye; N J Varadaxis; J A Reiss; D R Phillips
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

5.  In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.

Authors:  Rainer Ritz; Christian Scheidle; Susan Noell; Florian Roser; Martin Schenk; Klaus Dietz; Wolfgang S L Strauss
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

6.  In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.

Authors:  F M Rossi; D L Campbell; R H Pottier; J C Kennedy; E F Dickson
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

7.  Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.

Authors:  L Wyld; O Smith; J Lawry; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

8.  Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.

Authors:  E Debefve; B Pegaz; H van den Bergh; G Wagnières; N Lange; J-P Ballini
Journal:  Angiogenesis       Date:  2008-03-07       Impact factor: 9.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.